NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Each cash raise is smaller and smaller. That indicates to me a bridge funding to either a partnership or anticipated phase 3 results.

My read: the second purpose of favorable terms in this financing is to secure long term investors that will support the company even after partnership or positive phase 3 results are announced. Given the example of false attacks on Dendreon even after FDA approval, LP knows that there is a long game, where having multiple active supporting financial investors is an important leg stepping up to being a multi billion $ company. There is continued risk and loss on the books for the investors. I think there is an understanding in the background for their role.

Unfortunately focusing on the low stock price and dilution is a diversion because that is already the current reality, already history. The science will come. Linda has influence only over future actions like strategic investors and everything else leading up to sales (operations, manufacturing, regulators, etc).